![Evolus, Inc. logo](/logos/EOLS.webp)
Evolus, Inc.
NASDAQ:EOLS
Overview | Financials
Company Name | Evolus, Inc. |
Symbol | EOLS |
Currency | USD |
Price | 14.71 |
Market Cap | 928,120,095 |
Dividend Yield | 0% |
52-week-range | 7.44 - 16.29 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. David Moatazedi |
Website | https://www.evolus.com |
An error occurred while fetching data.
About Evolus, Inc.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD